GL1X · GenesisL1 explorer

MolNFT v1 · #122033 · protein

Crystal structure of equine serum albumin in complex with phosphorodithioate derivative of myristoyl cyclic phosphatidic acid (cpa)

5ID9: “Crystal structure of equine serum albumin in complex with phosphorodithioate derivative of myristoyl cyclic…”. X-ray diffraction, 1 ligand (6A4), 9 pockets (best druggability 0.79). MolNFT v1 #122033 on GenesisL1: 3D structure…

PDB
5ID9
Type
protein
Length
580 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Serum albumin
UniProt
F7BAY6
Ligands
6A4
Pockets
9 · best druggability 0.79

Structure

x-ray diffraction · 1 distinct chain · 74% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASerum albuminprotein58074% helix, 0% strandF7BAY6

Ligands and binding sites

  • 6A4 · (4S)-2-sulfanylidene-4-[(tetradecanoyloxy)methyl]-1,3,2lambda~5~-dioxaphospholane-2-thiolate · ligand · chains A
  • FMT · Formic acid · additive · 4 copies · chains A
  • MLI · Malonate ion · additive · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

9 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15640.790.8559MLI, FMT
28900.780.8160MLI, FMT
31750.670.8632empty
42130.620.8225FMT
52300.620.81276A4

Modifications

Observed in the structure: 17 disulfide (disulfide).

Compared structures

  • 5ID9 · Crystal structure of equine serum albumin in complex with phosphorodithioate derivative… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.